|Food preferences in human obesity: carbohydrates versus fats|
A Drewnowski, C Kurth, J Holden-Wiltse, J Saari
Appetite 18 (3), 207-221, 1992
|Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial|
JJ Treanor, GM Schiff, FG Hayden, RC Brady, CM Hay, AL Meyer, ...
Jama 297 (14), 1577-1582, 2007
|Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus|
H Miao, JA Hollenbaugh, MS Zand, J Holden-Wiltse, TR Mosmann, ...
Journal of virology 84 (13), 6687-6698, 2010
|Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults: AIDS Clinical Trials Group Protocols 150 and 258|
RM Gulick, V McAuliffe, J Holden-Wiltse, C Crumpacker, L Liebes, ...
Annals of internal medicine 130 (6), 510-514, 1999
|Simulation and prediction of the adaptive immune response to influenza A virus infection|
HY Lee, DJ Topham, SY Park, J Hollenbaugh, J Treanor, TR Mosmann, ...
Journal of virology 83 (14), 7151-7165, 2009
|Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team.|
BJ Dezube, JH Von Roenn, J Holden-Wiltse, TW Cheung, SC Remick, ...
Journal of clinical oncology 16 (4), 1444-1449, 1998
|Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine …|
LM Demeter, RW Shafer, PM Meehan, J Holden-Wiltse, MA Fischl, ...
Antimicrobial agents and chemotherapy 44 (3), 794-797, 2000
|High-resolution temporal response patterns to influenza vaccine reveal a distinct human plasma cell gene signature|
AD Henn, S Wu, X Qiu, M Ruda, M Stover, H Yang, Z Liu, SL Welle, ...
Scientific reports 3 (1), 1-12, 2013
|Taste responses and food preferences in obese women: effects of weight cycling|
A Drewnowski, J Holden-Wiltse
International journal of obesity and related metabolic disorders: journal of …, 1992
|Impact of prematurity and nutrition on the developing gut microbiome and preterm infant growth|
A Grier, X Qiu, S Bandyopadhyay, J Holden-Wiltse, HA Kessler, AL Gill, ...
Microbiome 5 (1), 1-19, 2017
|Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS|
JM Jacobson, R Hafner, J Remington, C Farthing, J Holden-Wiltse, ...
Aids 15 (5), 583-589, 2001
|A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease|
AJ Japour, JJ Lertora, PM Meehan, A Erice, JD Connor, BP Griffith, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 13 (3), 235-246, 1996
|Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals|
C Henry, NY Zheng, M Huang, A Cabanov, KT Rojas, K Kaur, SF Andrews, ...
Cell host & microbe 25 (3), 357-366. e6, 2019
|Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151|
MA Fischl, DD Richman, C Flexner, MF Para, R Haubrich, A Karim, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 15 (1), 28-34, 1997
|Modeling of influenza-specific CD8+ T cells during the primary response indicates that the spleen is a major source of effectors|
H Wu, A Kumar, H Miao, J Holden-Wiltse, TR Mosmann, AM Livingstone, ...
The Journal of Immunology 187 (9), 4474-4482, 2011
|ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy|
MF Para, P Meehan, J Holden-Wiltse, M Fischl, G Morse, R Shafer, ...
Antimicrobial agents and chemotherapy 43 (6), 1373-1378, 1999
|Neonatal gut and respiratory microbiota: coordinated development through time and space|
A Grier, A McDavid, B Wang, X Qiu, J Java, S Bandyopadhyay, H Yang, ...
Microbiome 6 (1), 1-19, 2018
|Transcriptomic biomarkers to discriminate bacterial from nonbacterial infection in adults hospitalized with respiratory illness|
S Bhattacharya, AF Rosenberg, DR Peterson, K Grzesik, AM Baran, ...
Scientific reports 7 (1), 1-12, 2017
|Dissociation, cellular isolation, and initial molecular characterization of neonatal and pediatric human lung tissues|
G Bandyopadhyay, HL Huyck, RS Misra, S Bhattacharya, Q Wang, ...
American Journal of Physiology-Lung Cellular and Molecular Physiology 315 (4 …, 2018
|Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-α2a in patients with HIV: AIDS Clinical Trials Group study 197|
MA Fischl, DD Richman, M Saag, TC Meng, KE Squires, J Holden-Wiltse, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 16 (4), 247-253, 1997